Inhalerx Ltd
ASX:IRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Inhalerx Ltd
Net Income (Common)
Inhalerx Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Inhalerx Ltd
ASX:IRX
|
Net Income (Common)
-AU$1.2m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
4DMedical Ltd
ASX:4DX
|
Net Income (Common)
-AU$165m
|
CAGR 3-Years
-80%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Net Income (Common)
$10.8m
|
CAGR 3-Years
46%
|
CAGR 5-Years
100%
|
CAGR 10-Years
N/A
|
|
|
Pro Medicus Ltd
ASX:PME
|
Net Income (Common)
AU$234.7m
|
CAGR 3-Years
66%
|
CAGR 5-Years
57%
|
CAGR 10-Years
48%
|
|
|
Alcidion Group Ltd
ASX:ALC
|
Net Income (Common)
AU$3.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Artrya Ltd
ASX:AYA
|
Net Income (Common)
-AU$16.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-65%
|
CAGR 10-Years
N/A
|
|
Inhalerx Ltd
Glance View
InhaleRx Ltd. engages in the development and commercialization of medical technologies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-01-11. The firm is focused on developing inhaled therapies and medicine delivery systems. The company offers Medihale, an inhaler device with sealed pod designed for use of medical cannabis inhaled formulations. The company utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper proof Medihale Pods provide patients with the additional Medical Cannabis c-liquid security. Its Medihale Starter Kit Pro comes with inhaler battery controller with universal serial bus (USB) charging cable, protective charging case and protective charging case USB charging cable.
See Also
What is Inhalerx Ltd's Net Income (Common)?
Net Income (Common)
-1.2m
AUD
Based on the financial report for Dec 31, 2024, Inhalerx Ltd's Net Income (Common) amounts to -1.2m AUD.
What is Inhalerx Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
13%
Over the last year, the Net Income (Common) growth was 16%. The average annual Net Income (Common) growth rates for Inhalerx Ltd have been -3% over the past three years , 13% over the past five years .
